Biotech entity

University of New Mexico

Company

Every one of those 1 sits in a single category, fda-approval. University of New Mexico is most often covered alongside America First Policy Institute, which appears in 1 of these 1 story. University of New Mexico appears in 1 tracked Biotech story from August 20, 2026.

Last mentioned: 3d ago

Entity pulse

Recent coverage · University of New Mexico

1 story
7 avg impact
0% positive
0% negative
  • 100% neutral

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about University of New Mexico

Every one of those 1 sits in a single category, fda-approval. University of New Mexico is most often covered alongside America First Policy Institute, which appears in 1 of these 1 story. University of New Mexico appears in 1 tracked Biotech story from August 20, 2026. The tracked stories average 2 original sources each.

Stories tracked
1
Sources per story
2

Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 3 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering University of New Mexico. Shared-story counts are live from our verified record — not editorial picks.

Timeline

  1. Trump announces Heidi Overton as FDA Commissioner nominee

    President Trump names the White House Domestic Policy Council deputy director to lead the FDA, pending Senate confirmation.

  2. Marty Makary resigns as FDA Commissioner

    The previous FDA head leaves behind unfinished projects on ultraprocessed foods, antidepressants, and COVID-19 shots.

Stories mentioning University of New Mexico 1

FDA Actions Neutral

Overton FDA Nomination: 4 Biopharma Risks From Drug Pricing to Vaccines

For biotech and pharma executives, Overton's nomination combines Trump's favored-nation drug pricing push with RFK Jr.'s vaccine skepticism and unfinished reviews of antidepressants and COVID shots. The result could compress margins while opening faster approval pathways for innovation. Investors should watch how she navigates evidence standards and political priorities at the FDA.

2 sources

Source: MedPage Today · Kstp Television

University of New Mexico is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.